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Abstract 
Perinatal exposure to a maternal junk food diet has been demonstrated to increase the 
preference for palatable diets in adult offspring. We aimed to determine whether this 
increased fat preference could be attributed to changes in mu-opioid receptor expression 
within the mesolimbic reward pathway. We report here that mRNA expression of the mu-
opioid receptor in the ventral tegmental area (VTA) at weaning was 1.4 fold (males) and 1.9 
fold (females) lower in offspring of junk food (JF) fed rat dams than in offspring of dams fed 
a standard rodent diet (control) (P<0.05). Administration of the opioid antagonist naloxone to 
offspring given a palatable diet post-weaning significantly reduced fat intake in control 
offspring (males: 7.7±0.7 vs. 5.4±0.6 g/kg/d; females: 6.9±0.3 vs. 3.9±0.5g/kg/d; P<0.05), but 
not in male JF offspring (8.6±0.6 vs. 7.1±0.5g/kg/d) and was less effective at reducing fat 
intake in JF females (42.2±6.0% vs. 23.1±4.1% reduction, P<0.05). Similar findings were 
observed for total energy intake. Naloxone treatment did not affect the intake of standard 
rodent feed in control or JF offspring. These findings suggest that exposure to a maternal junk 
food diet results in an early desensitization of the opioid system which may therefore explain 
the increased preference for junk food in these offspring.  
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Introduction  
Excessive maternal intake of high-fat and high-sugar ‘junk foods’ during pregnancy and 
lactation has been shown to program an increased preference for fat and sugar in juvenile and 
adult offspring (1-2). Since the preference for palatable food is thought to be regulated, at 
least in part, by activation of the mesolimbic reward pathway, this pathway has become the 
focus of studies attempting to determine the mechanisms underlying the programming effects 
of maternal palatable diets on offspring food preference (3-5). 
Within the mesolimbic reward system, opioid signaling plays a central role in eliciting the 
pleasurable sensation associated with rewarding stimuli (6-7). The consumption of palatable 
foods which are high in fat and sugar is associated with an increased concentration of 
endogenous opioids within the reward pathway (8-9) that then bind to opioid receptors in the 
ventral tegmental area (VTA) to stimulate dopamine release (10). Existing investigations into 
the mesolimbic reward pathway of adult rats exposed to a high-fat, high-sugar diet in utero 
and during the suckling period have highlighted mu-opioid receptor expression within this 
pathway as being particularly susceptible to alteration. We and others have demonstrated an 
increased expression of the mu-opioid receptor in the nucleus accumbens (NAc) of adult (3) 
and juvenile offspring (2) exposed to a palatable diet during the perinatal period.  
A possible explanation for the effects of a maternal palatable diet on mu-opioid receptor 
expression in the offspring is that high levels of endogenous opioids, as would be expected in 
response to a maternal palatable diet, may impact on opioid receptor ontogeny. However, the 
impact of palatable diets on the expression of the mu-opioid receptor in the early postnatal 
period is yet to be adequately explored. Previous studies that have examined the effect of 
maternal intake of the exogenous opioid, morphine, have shown that offspring exposed to 
morphine during the perinatal period have altered mu-opioid receptor expression, with the 
direction of this change dependent on the specific timing of the exposure (prenatal vs. 
postnatal) and the age of the offspring when expression is measured (11-12). Importantly, 
perinatally morphine-exposed offspring also exhibited an increased preference for sugar in 
adulthood (13). However, whether exposure to high levels of endogenous opioids during 
pregnancy and lactation could have similar effects remains to be determined. 
The sensitivity of the developing mu-opioid receptor to the nutritional environment and 
opioid concentrations during development, as well as its involvement in the regulation of 
palatable food intake, has led us to focus on the role of the opioid system in programming of 
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the preference for palatable food. Although alterations to mu-opioid receptor expression have 
been previously observed in adult offspring of dams fed a palatable diet during pregnancy 
and lactation (2-3) it remains unclear whether these changes in expression are present in the 
early postnatal period, prior to the increase in palatable food intake. It also remains to be 
determined whether or not changes in mRNA expression of the mu-opioid receptor at 
weaning in these perinatally junkfood exposed offspring have functional consequences for 
the subsequent regulation of palatable food intake in these offspring. Therefore, the aim of 
the current study was to determine whether exposure to a maternal ‘junk food’ diet during the 
perinatal period was associated with altered mu-opioid receptor expression in the offspring at 
weaning and if these changes impacted on the efficacy of the opioid antagonist naloxone in 
reducing the intake of palatable food in the immediate post-weaning period.  
 
Materials and Methods 
Animals and feeding regime 
This study was approved by the Animal Ethics Committee of the University of Adelaide. 17 
female and 4 male Albino Wistar rats were used in these experiments. The animals were 
allowed to acclimatize to the animal housing facility for 1 week prior to the commencement 
of the dietary intervention. During this period, all rats were fed a standard laboratory rodent 
feed (Specialty Feeds, Glen Forrest, WA, Australia). Following the acclimatization period, 
rats were assigned into weight matched groups to receive either a control (C, n=8) or junk 
food (JF, n=9) diet. The control diet consisted of the standard laboratory rodent feed 
(Specialty Feeds, Glen Forrest, WA, Australia). The junk food diet included hazelnut spread, 
peanut butter, chocolate biscuits, savoury snacks, sweetened cereal and a lard and chow mix. 
Detailed nutritional information on this diet has been previously published (2). Food intake 
was determined every 2 days by subtracting the amount left uneaten in the cage from the 
amount initially supplied and rats were weighed weekly for the duration of the experiment. 
All animals were individually housed and kept at a room temperature of 25°C in a 12 hour/12 
hour light-dark cycle throughout the experiment. 
 
The female rats were provided with their respective diets for 2 weeks prior to mating and 
throughout pregnancy and lactation. Females were mated with 4 proven males (same males 
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used for both control and junk food groups), that were maintained on the standard laboratory 
rodent feed. Vaginal smears were performed to determine the stages of the estrous cycle. On 
the night of di-estrous/pro-estrous, the female rat was placed with a male overnight and 
vaginal smears were conducted the following morning. The presence of sperm in the vaginal 
smears was considered as confirmation of successful mating and was designated as gestation 
day 0. 
Pups were born on day 21-22 of gestation. On the day after birth (postnatal day (PND) 1), 
pups were culled to 8 per litter, 4 males and 4 females where possible. Pups were weighed 
every 2 days during the suckling period and were weaned on PND 21. Pups of control and JF 
dams are referred to as control offspring and JF offspring respectively. 
Determination of mu-opioid receptor gene expression in the NAc and VTA 
At weaning, a subset of both male (control n=10, JF n=9) and female pups (control n=8, JF 
n=8) were killed and whole brains removed. The NAc and VTA were isolated using 
stereotaxic coordinates and microdissection as described previously (2). Total RNA was 
extracted from these respective brain regions using Trizol reagent (Invitrogen Australia, 
Mount Waverley, Vic, Australia) and purified with an RNeasy Mini Kit (Qiagen Australia, 
Doncaster, Vic, Australia). cDNA was synthesized from the purified RNA using Superscript 
III reverse transcriptase (Invitrogen Australia, Mount Waverley, Vic, Australia) and random 
hexamers. Real-time qRT-PCR was performed on the LightCycler® 480 Real Time PCR 
System (Roche Diagnostics, Mannheim, Germany) using the SYBR green system. The 
primer sequences used for the mu-opioid receptor, have been previously published (2), 
mRNA expression of the reference gene β-actin was measured using the β-actin Quantitect 
primer assay (Qiagen Australia, Doncaster, Vic, Australia). The amplification efficiency of 
the primers was 0.997-0.999 and 2 quality controls were added to each plate to verify 
interplate consistency. The expression of mu-opioid receptor mRNA relative to β-actin 




Pups not used for gene expression analysis were housed with a same sex littermate and were 
randomly assigned to receive a daily intraperitoneal injection of either naloxone (5mg/kg) or 
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an equivalent volume of saline for 10 days post-weaning. Naloxone hydrochloride dihydrate 
(5mg, purchased from Sigma Aldrich, St Louis, MO, USA) was dissolved in 10ml of sterile 
saline (a separate aliquot for each animal) and stored away from light at 4°C for the duration 
of the experiment. Rat pups were weighed prior to each injection to ensure accurate dosing. 
Injections were given 30 minutes prior to the onset of the dark cycle (5:30pm). This 
generated four groups, the offspring exposed to a control diet before weaning and given 
saline injections (C-C, n=16), the offspring exposed to a control diet before weaning and 
given naloxone injections (C-N, n=16), the offspring exposed to junk food before weaning 
and given saline injections (JF-C, n=17) and the offspring exposed to junk food diet prior to 
weaning and given naloxone injections (JF-N, n=17) (Fig. 1).  
 
Determination of food preferences 
Immediately following the administration of the naloxone/saline injections, the rats were 
returned to their home cage and provided with free access to both the standard laboratory 
rodent feed (Specialty Feeds, Glen Forrest, WA, Australia) and the junk food diet until the 
time of the next injection 24 hours later. Due to the short half-life of naloxone, food intake of 
the offspring was measured in the 2 hour period immediately following injection (the period 
during which naloxone has previously been shown to persist in the brain at concentrations 
capable of inhibiting food intake (14)), as well as during the entire 24 hour period in all 
offspring. 
Food intake was calculated by subtracting the amount left uneaten after the 2 or 24 hour time 
points from the amount supplied at the beginning of each period. The amount of standard 
laboratory rodent feed and each different type of junk food consumed over each 2 and 24 
hour period was recorded and macronutrient preferences were calculated based on the 
nutritional composition of each food type. The amount of food consumed was normalized to 
offspring body weight. For all statistical analysis, pups in the same cage were considered as 
one unit.  At the conclusion of the 10 day injection period (PND 31) pups were killed and 
tissues collected. 
Post-mortem and tissue collection 
Post-mortems were performed between 0800 and 1200 with rats weighed immediately prior 
to euthanasia. Blood samples were collected in heparinised tubes via cardiac puncture and 
centrifuged at 3,500 g at 4ºC for 15 minutes. Body weight, length (nose to tail) and 
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abdominal circumference were determined. All internal organs were weighed and all visible 
fat depots, including omental fat, retroperitoneal fat, gonadal fat, subcutaneous fat and 
interscapular fat, were dissected to determine the fat mass of individual fat depots and total 
fat mass. The weight of all internal organs and fat were expressed relative to body weight. All 




Analysis of maternal food intake and body weight data as well as birth outcomes was 
conducted using Student’s unpaired t-tests. The effect of maternal diet on mu-opioid receptor 
mRNA expression was analysed by two-way ANOVA with maternal treatment and sex as 
factors. The effect of naloxone treatment on the food intake of post-weaning offspring was 
analysed by one-way ANOVA in each sex, followed by Duncan’s post-hoc analysis. Where 
significant differences in food intake (g/kg/2hr) between the saline and naloxone groups were 
observed for both control and JF offspring, Student’s unpaired t-tests were used to compare 
the magnitude of the change in food intake caused by naloxone treatment between maternal 
treatment groups. One and two-way ANOVA, as well as the Student’s unpaired t-tests, were 
performed using SPSS statistics 18.0 software (SPSS Inc., Chicago, IL, USA). Offspring 
body weight gain was analysed by two-way repeated measures ANOVA, which was 
performed using Stata 11 software (StataCorp., TX, USA). Male and female offspring were 
analysed separately for all measures except where stated. All data presented as mean±SEM 
with a P value of <0.05 considered statistically significant. 
 
Results 
Dam body weight and nutritional intake during pregnancy and lactation 
There was no difference in body weight between the control and JF dams prior to mating 
(control 332.8±9.6g, JF 324.1±9.4g) or throughout pregnancy. During pregnancy, the JF 
dams consumed significantly more fat than the controls (control 3.14±0.2g/kg/d, JF 
14.8±1.12g/kg/d, P<0.01) without any differences in protein, carbohydrate, or overall energy 
intake. Throughout lactation, in addition to increased fat intake (control 6.26±0.3g/kg/d, JF 
25.2±1.9g/kg/d, P<0.01) the JF dams also consumed less protein (control 26.7±1.3g/kg/d, JF 
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15.4±1.1g/kg/d, P<0.05) and carbohydrate (control 81.7±4.1g/kg/d, JF 63.1±4.1g/kg/d, 
P<0.05) compared to control dams. 
 
Effect of maternal diet on birth outcomes and pup growth  
Maternal diet had no effect on litter size (control 14.6±0.8, JF 13.2±1.2) or the percentage of 
males per litter (control 53.2±4.0%, JF 60.6±5.1%). Offspring of JF dams had a significantly 
lower birth weight for both the male (control 7.0±0.2g, JF 6.0±0.1g, P<0.01) and female pups 
(control 6.4±0.2g, JF 5.7±0.2g, P<0.05). The offspring of JF dams remained lighter than 
controls throughout the suckling period and were still significantly lighter than control 
offspring at weaning (PND 21) in both males and females (male control 53.7±1.7g, male JF 
45.0±1.1g; female control 52.3±1.6g, female JF 43.9±0.8g, P<0.01). 
 
Effect of maternal diet on the expression of the mu-opioid receptor in the NAc and VTA of the 
offspring at weaning 
The mRNA expression of the mu-opioid receptor in the VTA at weaning was lower in 
offspring of JF dams compared to controls in both males and females (Fig. 2A P<0.05). In 
the NAc, mu-opioid receptor mRNA expression at weaning was higher in male offspring of 
JF dams compared to controls (Fig. 2B P<0.05). There was no effect of maternal junk food 
feeding on mu-opioid receptor expression in the NAc at weaning in female offspring 
(Fig.2B). 
 
Effect of maternal diet and naloxone treatment on offspring growth and body composition 
Naloxone treatment had no effect on body weight at any time point during the experiment in 
either the control or JF offspring. At the end of the injection period (10 days after weaning), 
both male (C-C 102.6±4.0g, C-N 103.8±3.9g, JF-C 83.3±2.6g, JF-N 88.2±1.8g, P<0.01) and 
female (C-C 98.5±3.7g, C-N 101.7±4.4g, JF-C 82.8±2.3g, JF-N 82.5±2.8g, P<0.01) offspring 
of JF dams were significantly lighter than controls, independent of whether they were treated 
with saline or naloxone. In males, offspring of JF dams had a higher subcutaneous fat mass 
compared to control offspring independent of whether they received saline or naloxone 
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(Table 1, P<0.05); no effect of group was observed on the weight of any other fat depots or 
total fat mass (Table 1). There was no effect of either maternal diet or naloxone treatment on 
fat deposition in female offspring (Table 1). 
 
Effect maternal diet and naloxone treatment on offspring food intake 
2hrs post injection 
In control offspring, the intake of fat, carbohydrate, protein and total energy were all 
significantly reduced in the 2 hours post injection in those offspring receiving naloxone 
injections, compared with those administered saline in both males and females (Fig. 3A-D, 
P<0.05). In the offspring of JF dams, however, naloxone treatment either had no effect on 
intake, or supressed food intake to a significantly lesser extent when compared to the effects 
observed in offspring of control dams.  
In the male offspring of JF dams, there was no effect of naloxone treatment on fat intake in 
the 2 hours post injection (Fig. 3A). In female JF offspring, the decrease in fat intake in 
naloxone-treated offspring compared to their saline-treated counterparts was significantly less 
than that observed in the offspring of control dams (control 42.2±6.0% reduction, junk food 
23.1±4.1% reduction, P<0.05) (Fig. 3A).  
Total energy intake in both sexes and the intake of carbohydrate in males only, were 
significantly reduced in the naloxone treated offspring of JF dams compared to their saline 
treated counterparts during the 2 hours post injection. However, in all cases, the magnitude of 
these effects was significantly less than observed in the offspring of control dams (Fig. 3B, 
D). Naloxone treatment failed to significantly reduce protein intake in the JF offspring in 
both males and females and carbohydrate intake in female JF offspring was also not different 
between naloxone and saline treated animals (Fig. 3C-D).  
Analysis of intake of specific junk foods, showed that, in female offspring of both control and 
JF dams, consumption of hazelnut spread (C-C 5.7±0.8g/kg/d, C-N 2.8±0.5g/kg/d, JF-C 
7.1±0.7g/kg/d and JF-N 4.8±0.7g/kg/d, P<0.01) and peanut butter (C-C 3.5±0.8g/kg/d, C-N 
2.1±0.7g/kg/d, JF-C 5.9±0.6g/kg/d and JF-N 3.6±0.9g/kg/d, P<0.05) were significantly 
inhibited by naloxone. There were no other significant effects of naloxone treatment on the 
intake of other specific junk foods in either male or female offspring.  
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The effects of naloxone on food intake appeared to be specific to the junk food diet, since 
intake of the standard rodent feed offered at the same time was not significantly altered by 
naloxone treatment in either control or JF offspring in either males (C-C 7.8±1.3g/kg, C-N 
5.5±1.2g/kg, JF-C 9.45±1.6g/kg, and JF-N 7.2±1.0g/kg) or females (C-C 6.0±1.3g/kg, C-N 
3.4±1.2g/kg, JF-C 6.8±1.0g/kg, and JF-N 8.0±1.8g/kg). 
24hrs post injection 
In females only, offspring of JF dams consumed significantly more fat than their control 
counterparts (Fig. 4A, P<0.05). There were no effects of the naloxone treatment on intake of 
either total energy or any individual macronutrients in either the control or JF offspring (Fig. 
4B-D). There was also no difference in the intake of either the standard rodent feed or any 
individual junk food between saline and naloxone treated offspring.  
Investigation into the intake of individual foods revealed that, for females only, the offspring 
of JF dams consumed significantly less sweetened cereal than controls independent of 
injection treatment (C-C 32.9±3.9g/kg/d, C-N 38.3±7.2g/kg/d, JF-C 13.9±2.5g/kg/d and JF-N 
17.5±6.2g/kg/d, P<0.01). No difference in intake between groups was observed for the other 
junk foods or in male offspring. There was no effect of either maternal diet or naloxone 
treatment on the intake of the standard rodent feed in either male (C-C 74.6±8.8g/kg/d, C-N 
89.2±11.4g/kg/d, JF-C 82.2±12.4g/kg/d and JF-N 104.6±21.0g/kg/d) or female (C-C 




In the present study, we have shown that exposure to a maternal palatable diet during 
pregnancy and lactation is associated with altered expression of the mu-opioid receptor in 
both the VTA and NAc at weaning in a region- and sex-specific manner, demonstrating for 
the first time that the effects of perinatal junk food exposure on the opioid system are already 
present immediately following the exposure. We have also demonstrated that the opioid 
receptor antagonist naloxone was less effective at reducing the intake of palatable food in 
offspring exposed to a junk food diet during the perinatal period, consistent with a reduced 
sensitivity to opioids in these offspring. This study is the first to demonstrate that the changes 
in mu-opioid receptor expression previously observed in adult offspring of junk food fed 
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dams are already present at weaning and that these changes in expression have functional 
consequences for the regulation of palatable food intake. This work provides important and 
novel insights into the pathway linking perinatal exposure to a palatable diet with a 
heightened preference for these foods after birth and adds to the ever growing body of 
evidence suggesting that a maternal junk food diet can alter the development of the reward 
pathway of the offspring and that these changes affect food choices from weaning into 
adulthood.  
Maternal junk food consumption decreases rate of postnatal growth of offspring 
Consistent with previous studies (1-2), the offspring of junk food fed dams were born smaller 
and remained smaller than their control counterparts throughout the suckling period. This 
reduction in body size has been previously attributed to reductions in protein intake; however 
in the current model, protein intake did not differ between maternal groups during gestation. 
Thus, the decreased birth weight of the offspring of junk food fed dams appears to be driven 
by a mechanism other than protein deficiency. Clinical studies have suggested that maternal 
obesity is associated with poor placental function (15-16), which could contribute to growth 
deficits. In this study, however, maternal body weight was not different between groups; 
hence this is unlikely to explain the differences in offspring growth. Whilst the caloric intake 
of the junk food dams was increased relative to controls, our preliminary analysis of the junk 
food diet suggests that it is deficient in a number of key micronutrients, including magnesium 
and calcium. Deficiencies of both these micronutrients have been associated with poor fetal 
growth outcomes clinically (17-18) and therefore may provide an explanation for the reduced 
birthweight of the junk food offspring.  
During lactation, the protein intake of JF dams was significantly lower than controls, which is 
likely to have exacerbated the effect of any other nutrient deficiencies present during 
gestation and contributed to the reduced body weight of the offspring, since exposure to a 
low-protein diet during the suckling period has been consistently shown to reduce the body 
weight of offspring (19-20). In addition to reduced protein intake, junk food fed dams have 
been reported to have reduced milk production (21) which may explain the reduction of body 
weight during the last 2 weeks of lactation in junk food dams, since these animals may have 
to invest greater energy into lactogenesis (21). Difficulties lactating or nutrient deficiency of 
the milk would also provide an explanation for the lower weight gain of the pups across the 
suckling period.  
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Maternal junk food diet decreases expression of mu-opioid receptor in VTA 
An important finding of the present study was that alterations to the mRNA expression of the 
mu-opioid receptor in key regions of the mesolimbic reward system were already present at 
weaning in the offspring of dams fed a junk food diet during pregnancy and lactation. 
Interestingly, these changes in expression appeared to be dependent on the specific region of 
the reward pathway examined, with decreased mu-opioid receptor expression observed in the 
VTA of both sexes and increased expression observed in the NAc of male offspring only. A 
possible explanation for this disparity of expression between brain areas is their differing 
rates of development. The appearance and subsequent increase in abundance of the mu-
opioid receptor  in the brain during development follows a caudal to rostral pattern (22), such 
that mu-opioid receptor proliferation in the VTA occurs earlier in development than that in 
the NAc. The effects of opioids on receptor development are greatest at times of rapid 
proliferation (23) and given our hypothesis that the differences in expression in the offspring 
of junk food fed dams may be driven by increases in maternal endogenous opioids, it may be 
that the effect on expression is different depending on the stage of development at which the 
exposure to increased opioid concentrations occurs.  
Whilst the current work is the first to investigate the effect of a maternal junk food diet on 
mu-opioid receptor expression at weaning, previous studies have reported changes in mRNA 
expression of the mu-opioid receptor in the adult offspring of junk food fed dams. Vucetic et 
al. demonstrated that adult offspring of dams fed a palatable diet and weaned onto a standard 
rodent feed, had an increased expression of the mu-opioid receptor in the NAc at 18-24 
weeks of age (3), whereas studies in our own laboratory have shown that offspring of junk 
food dams weaned onto a junk food diet exhibited an increased expression of the mu-opioid 
receptor mRNA in the NAc at 6 weeks of age and decreased expression in adulthood after 
being maintained on a junk food diet post-weaning (2). Interestingly, we found no changes in 
the expression of mu-opioid receptors in the VTA in that same study (2).  Viewing these 
results in light of the current findings suggests that, at least in male offspring, a maternal junk 
food diet increases the expression of the mu-opioid receptor in the NAc at weaning and that 
this increased expression can persist until adulthood if offspring are weaned onto a standard 
rodent diet. However, previous work in our own laboratory has revealed that this expression 
pattern can be reversed by prolonged exposure to a junk food diet during adolescence (2). 
The studies in the adult offspring of JF dams have focused primarily on changes in gene 
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expression in the NAc rather than the VTA, and it is apparent that further studies are required 
to better elucidate the effect of a maternal junk food diet on the VTA in adulthood  
 
Maternal junk food consumption decreases the effectiveness of naloxone in the offspring 
This is the first study to directly demonstrate that changes in mu-opioid receptor expression 
induced by exposure to a maternal junk food diet have functional consequences for the 
regulation of palatable food intake in the offspring. We found that the offspring of junk food 
fed dams were significantly less sensitive to the inhibitory effects of the opioid receptor 
antagonist naloxone on palatable food intake than offspring of control dams. Naloxone was 
selected as the antagonist as it only persists at concentrations capable of reducing food intake 
for two hours post injections (14), this acute treatment was selected to minimize the impact 
prolonged suppression of food intake would have on the growth of the pups. In line with this, 
we did not observe any difference in body weight between those pups given saline and those 
given naloxone within the same maternal dietary group.  
Previous studies conducted in adult rodents have demonstrated that the effectiveness of 
naloxone at inhibiting food intake is dependent on the palatability of the food being 
consumed (9, 24). Consistent with this, we observed no effect of naloxone treatment on the 
intake of the standard rodent feed in the current study, suggesting that the observed changes 
in macronutrient intake were specifically due to reduced consumption of palatable foods, 
rather than an overall decrease in food intake.  However, unlike previous studies which have 
reported the suppressive effect of naloxone to be fat specific (14, 25), we observed decreases 
in the intake of all macronutrients (protein, fat, carbohydrate) in the offspring of control 
mothers where treatment was most effective. This can most likely be attributed to the fact that 
a number of the junk foods provided to the offspring were high in both fat and sugar making 
it difficult to distinguish between the effects on intake of these different macronutrients. 
Similarly, the effects on protein intake were likely caused by the inhibitory effect of naloxone 
on peanut butter intake which contains approximately 50% fat and 20% protein. 
The reduced sensitivity of the offspring of junk food fed dams to the effects of naloxone on 
palatable food intake suggests that there was reduced mu-opioid receptor binding in the 
reward pathway of these offspring. Naloxone is a non-specific opioid receptor antagonist, 
which binds preferentially to the mu-opioid receptor over kappa or delta receptors (26). 
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Naloxone binding to the mu-opioid receptor is thought to inhibit palatable food intake by 
blocking the binding of endogenous opioids which have been demonstrated to stimulate the 
intake of high-fat high-sugar foods (8, 27). Reduced sensitivity to the effects of naloxone in 
the junk food offspring is in agreement with our finding of reduced mu-opioid receptor 
expression in the VTA of these offspring at weaning. Mu-opioid receptor binding in the VTA  
regulates the release of dopamine into the NAc, which is the major terminal area of A10 
dopamine neurons (28). This may suggest that it is mu-opioid receptor involvement in the 
control of dopamine release which is the critical mechanism altered by exposure to a junk 
food diet during the perinatal period. That opioid regulation of dopamine is involved in the 
programming of food preferences is supported by studies looking at adult offspring of junk 
food fed dams which have demonstrated changes in both the opioid and dopamine systems of 
these animals (3-4, 29). 
One possibility is that the observed decreases in mu-opioid expression and reduced sensitivity 
to naloxone in the offspring of junk food fed dams may be a result of exposure to elevated 
levels of endogenous opioids caused by maternal junk food consumption. Opioids have been 
previously demonstrated to readily cross the placenta (30) and into breastmilk (31-32), 
suggesting that increases in maternal opioid levels are likely to result in increased 
concentrations of opioids in fetal and neonatal circulation. Studies looking at the effect of 
maternal intake of an exogenous opioid (morphine) on mu-opioid receptor expression (as 
measured by naloxone binding studies post-mortem) have generated conflicting results, with 
one study reporting increased mu-opioid receptor expression (33) and others decreased 
expression (12, 34). This variation of results is likely due to differences in brain area 
explored, sex of animals studied and the timing of exposure. The relevance of these models to 
the current study must be considered with caution as there is evidence to suggest that 
exogenous and endogenous opioids may act through different mechanisms (35-36). 
Investigation into the role of maternal endogenous opioids on mu-opioid receptor expression 
in the offspring is very limited. Zadina et al reported that administration of the endogenous 
opioid β-endorphin before birth resulted in increased mu-opioid receptor expression in the 
whole brain of male offspring, whilst postnatal injections caused a decrease in expression 
(37). The lack of literature exploring the effect of endogenous opioids on the developing 
reward pathway creates a need for future investigation, particularly as relates to the 
programming effects of a maternal junk food diet which may be largely opioid mediated.  
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Temporary inhibition of appetite by naloxone drives compensatory increases in food intake  
In the current study, we observed that the offspring of control dams given naloxone 
consumed significantly more total energy from 2 to 24 hours post injection compared to those 
administered saline, this effect was not observed in the offspring of junk food fed dams. We 
suggest that the increased energy consumed by the offspring of control dams was a 
compensatory mechanism to overcome the time of caloric restriction induced by naloxone. 
This finding is in agreement with studies in adult rodents which have also demonstrated an 
increase in energy intake after the initial suppression of consumption by naloxone injection 
(38-39). That this compensatory increase in energy intake was not observed in the offspring 
of junk food fed dams, supports the finding that naloxone was less effective at inhibiting food 
intake in these animals. 
 
Sex differences in the programming of food preferences by a maternal junk food diet 
We observed that female, but not male, offspring of junk food fed dams had higher fat intake 
compared to controls during the first 10 days post-weaning. This was in contrast to previous 
work in adult offspring which reported a higher preference for fat across both sexes in 
offspring exposed to a junk food diet during the perinatal period (1-2). However, in a 
maternal low-protein diet model, female offspring of the low protein dams had a higher fat 
intake when compared to their control counterparts, whereas the same effect was not 
observed in males (19). Therefore, there is some evidence to suggest that the regulation of fat 
intake in females may be more susceptible to alteration by maternal diet before birth and 
early in life than that of male offspring. The differences in fat intake between males and 
females may be attributed to differences in the rate of development of the opioid system 
between the sexes, however this is poorly explored in the literature and there remains a need 
for further investigation. Another possible explanation for the sex-specific effect observed is 
differences in the concentrations of gonadal hormones between the sexes, as estrogen has 
previosuly been implicated in the regulation of the endogenous opioid system (40).  
Despite our finding that it was only the female offspring junk food fed dams that had an 
increased preference for junk food in early life; it was the male and not female offspring who 
had an increase in subcutaneous fat mass. The difference in fat mass in male offspring but not 
females could be attributed to differences in fat metabolism (41). Nevertheless, the lack of 
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differences in total fat deposition observed between the control and junk food offspring in 
this study has also been previously reported when both the control and junk food offspring 
were weaned on the junk food and control diet until 6 weeks and 3 months of age (2).  
 
Summary and Speculation 
The present study is the first to demonstrate that a maternal junk food diet during pregnancy 
and lactation has functional consequences on the reward pathway of the offspring 
immediately post-weaning, by reducing the ability of an opioid receptor antagonist to 
suppress the intake palatable food. This study also shows that the alterations in opioid 
receptor expression are already present at weaning and can impact on the regulation of food 
preferences in the offspring even at this early age. Furthermore, it is likely that decreases in 
mu-opioid receptor expression and sensitivity present at weaning could have a longer term 
impact on the food choices of these offspring, as there would be a need to increase palatable 
food intake to overcome this early desensitization. We speculate that these changes in the 
expression and functionality of the opioid system in offspring exposed to a junk food diet 
during the perinatal period may be a result of exposure to high levels of endogenous opioids 
generated by maternal palatable food consumption (Fig. 5), and it will be important to 
investigate this hypothesis directly in future studies. This work has provided novel insights 
into a potential mechanism through which a maternal junk food diet increases the preference 
for junk food in the offspring. A better understanding of this mechanism is crucial if we are to 
develop possible strategies for intervention and becomes increasingly important in view of 
the rapidly rising rates of both childhood and adult obesity.  
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Figure 2. 
  A. 
B. Mu NAc

































MATERNAL PALATABLE DIET AND OPIOID DESENSITIVITY   20 
 
  
Table 1.Fat depots as a percentage of body weight in male and female offspring of control or JF dams after repeated 
daily intraperitoneal injections with saline or naloxone for 10 days post-weaning (PND 31) 
                             




Parameter C-C C-N JF-C JF-N C-C C-N JF-C JF-N  
Omental fat 0.7±0.05 0.8±0.06 0.9±0.04 0.7±0.04  0.8±0.05 0.8±0.05 0.8±0.04 0.7±0.06 
Retroperitoneal fat 1.0±0.13 1.1±0.08 0.9±0.06 1.1±0.04  0.9±0.09 0.9±0.05 0.8±0.02 0.8±0.08 
Epigonadal fat 0.7±0.04 0.7±0.03 0.6±0.06 0.6±0.04  0.9±0.05 0.9±0.08 0.7±0.10 0.7±0.06 
Interscapular fat 0.6±0.07 0.7±0.08 0.5±0.05 0.6±0.06  0.6±0.04 0.6±0.05 0.5±0.03 0.5±0.04 
Subcutaneous fat 6.0±0.41a 6.4±0.27ab 7.2±0.44bc 7.8±0.33c  7.8±0.28 6.9±0.48 7.6±0.46 7.9±0.59 
Total fat 9.1±0.52 9.8±0.29 10.1±0.58 10.7±0.42  10.8±0.39 10.0±0.62 10.1±0.48 10.6±0.75 
Values are expressed mean ± SEM., different superscript letters denote values that are significantly different, P<0.05 
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Figure 1 Experimental design. Dams were given either a control or junk food diet throughout 
pregnancy and lactation (control n=8, JF n=9). At weaning (3wk) tissue samples were taken and gene 
expression analysis conducted on a subset of pups (control n=18, JF n=17). Remaining pups, (control 
n=32, JF n=34) were designated to receive either a saline or naloxone injection daily for 10 days post-
weaning.  
Figure 2 Expression of the mu-opioid receptor in male and female offspring of control (open bars, 
n=18) and junk food dams (closed bars, n=17) in (A) the VTA and (B) the NAc at weaning (PND 21). 
Results presented as mean±SEM, * indicates P<0.05.  
Figure 3 Intake of fat (A), total energy (B), protein (C) and carbohydrate (D) 2 hours post injection of 
male and female offspring of control dams given saline (C-C, open bars) or naloxone (C-N, closed 
bars) and offspring of junk food dams given saline (JF-C, striped bars) or naloxone (JF-N, grey 
shaded bars). Results presented as mean±SEM, n=8 pups for all groups except JF-C and JF-N in the 
male offspring, where n=9. Different letters above the bars denotes mean values which are 
significantly different P<0.05. 
Figure 4 Intake of fat (A), total energy (B), protein (C) and carbohydrate (D) 24 hours post injection 
of male and female offspring of control dams given saline (C-C, open bars) or naloxone (C-N, closed 
bars) and offspring of junk food dams given saline (JF-C, striped bars) or naloxone (JF-N, grey 
shaded bars). Results presented as mean±SEM, n=8 pups for all groups except JF-C and JF-N in the 
male offspring, where n=9. Different letters above the bars denote mean values which are 
significantly different P<0.05. 
Figure 5. Summary of proposed mechanism through which a maternal junk food diet could establish 
the preference for palatable food in offspring. We speculate that maternal consumption of a junk food 
diet throughout pregnancy and lactation acts to increase maternal endogenous opioids levels. These 
opioids are then transferred to the offspring via the placenta and/or through the breast milk and act on 
the developing reward pathway to decrease expression of the mu-opioid receptor in the VTA. The 
resulting densitization to the effect of endogenous opioids in the offspring of junk food fed mothers 
would drive an increased intake of palatable foods in order to achieve the same level of stimulation in 









1. Bayol, S. A., Farrington, S. J., and Stickland, N. C. (2007) A maternal "junk food" diet in 
pregnancy and lactation promotes an exacerbated taste for "junk food" and a greater 
propensity for obesity in rat offspring. Brit J Nut 98, 843-851 
2. Ong, Z. Y., and Muhlhausler, B. S. (2011) Maternal "junk-food" feeding of rat dams alters 
food choices and development of the mesolimbic reward pathway in the offspring. FASEB J 
25, 2167-2179 
3. Vucetic, Z., Kimmel, J., Totoki, K., Hollenbeck, E., and Reyes, T. M. (2010) Maternal High-
Fat Diet Alters Methylation and Gene Expression of Dopamine and Opioid-Related Genes. 
Endocrinology 151, 4756-4764 
4. Naef, L., Srivastava, L., Gratton, A., Hendrickson, H., Owens, S., and Walker, C.-D. (2008) 
Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the 
adult rat offspring: reduction in the behavioral responses to repeated amphetamine 
administration. Psychopharmacology (Berl.) 197, 83-94 
5. Teegarden, S. L., Scott, A. N., and Bale, T. L. (2009) Early life exposure to a high fat diet 
promotes long-term changes in dietary preferences and central reward signaling. 
Neuroscience 162, 924-932 
6. Kelley, A. E., Bakshi, V. P., Haber, S. N., Steininger, T. L., Will, M. J., and Zhang, M. (2002) 
Opioid modulation of taste hedonics within the ventral striatum. Physiol. Behav. 76, 365-377 
7. Van Ree, J. M., Niesink, R. J. M., Van Wolfswinkel, L., Ramsey, N. F., Kornet, M. M. W., 
Van Furth, W. R., Vanderschuren, L. J. M. J., Gerrits, M. A. F. M., and Van den Berg, C. L. 
(2000) Endogenous opioids and reward. Eur. J. Pharmacol. 405, 89-101 
8. Zhang, M., Gosnell, B. A., and Kelley, A. E. (1998) Intake of High-Fat Food Is Selectively 
Enhanced by MuOpioid Receptor Stimulation within the Nucleus Accumbens. J. Pharmacol. 
Exp. Ther. 285, 908-914 
9. Giraudo, S. Q., Grace, M. K., Welch, C. C., Billington, C. J., and Levine, A. S. (1993) 
Naloxone's anorectic effect is dependant upon the relative palatability of food. Pharmacol 
Biochem and Behav 46, 917-921 
10. Bergevin, A., Girardot, D., Bourque, M.-J., and Trudeau, L.-E. (2002) Presynaptic [mu]-
opioid receptors regulate a late step of the secretory process in rat ventral tegmental area 
GABAergic neurons. Neuropharmacology 42, 1065-1078 
11. Handelmann, G. E., and Quirion, R. (1983) Neonatal exposure to morphine increases [mu] 
opiate binding in the adult forebrain. Eur. J. Pharmacol. 94, 357-358 
12. Tempel, A., Habas, J. E., Paredes, W., and Barr, G. A. (1988) Morphine-induced 
downregulation of [mu]-opioid receptors in neonatal rat brain. Dev Brain Res 41, 129-133 
13. Gagin, R., Cohen, E., and Shavit, Y. (1996) Prenatal exposure to morphine alters analgesic 
responses and preference for sweet solutions in adult rats. Pharmacol Biochem and Behav 55, 
629-634 
14. Marks-Kaufman, R., and Kanarek, R. B. (1981) Modifications of nutrient selection induced 
by naloxone in rats. Psychopharmacology (Berl.) 74, 321-324 
15. Stewart, F. M., Freeman, D. J., Ramsay, J. E., Greer, I. A., Caslake, M., and Ferrell, W. R. 
(2007) Longitudinal Assessment of Maternal Endothelial Function and Markers of 
Inflammation and Placental Function throughout Pregnancy in Lean and Obese Mothers. J. 
Clin. Endocrinol. Metab. 92, 969-975 
16. Lappas, M., Yee, K., Permezel, M., and Rice, G. E. (2005) Release and regulation of leptin, 
resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue 
and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. 
J. Endocrinol. 186, 457-465 
17. Repke, J. T., and Villar, J. (1991) Pregnancy-induced hypertension and low birth weight: the 
role of calcium. Am J Clin Nutr 54, 237S-241S 
MATERNAL PALATABLE DIET AND OPIOID DESENSITIVITY   26 
 
18. Takaya, J., Yamato, F., and Kaneko, K. (2006) Possible relationship between low birth weight 
and magnesium status: from the standpoint of “fetal origin” hypothesis. Magnes. Res. 19, 63-
69 
19. Bellinger, L., Lilley, C., and Langley-Evans, S. C. (2004) Prenatal exposure to a maternal 
low-protein diet programmes a preference for high-fat foods in the young adult rat. Brit J Nut 
92, 513-520 
20. Zambrano, E., Bautista, C., Deas, M., Martínez Samayoa, P., González Zamorano, M., 
Ledesma, H., Morales, J., Larrea, F., and Nathanielsz, P. (2006) A low maternal protein diet 
during pregnancy and lactation has sex and window of exposure specific effects on offspring 
growth and food intake, glucose metabolism and serum leptin in the rat. J Physiol 571, 221-
230 
21. Rolls, B. J., and Rowe, E. A. (1982) Pregnancy and lactation in the obese rat: Effects on 
maternal and pup weights. Physiology &amp; Behavior 28, 393-400 
22. Bardo, M. T., Bhatnagar, R. K., and Gebhart, G. F. (1981) Opiate receptor ontogeny and 
morphine-induced effects: Influence of chronic footshock stress in preweanling rats. Dev 
Brain Res 1, 487-495 
23. Bardo, M. T., Bhatnagar, R. K., and Gebhart, G. F. (1983) Age-related differences in the 
effect of chronic administration of naloxone on opiate binding in rat brain. 
Neuropharmacology 22, 453-461 
24. Glass, M. J., Grace, M., Cleary, J. P., Billington, C. J., and Levine, A. S. (1996) Potency of 
naloxone's anorectic effect in rats is dependent on diet preference. Am J Physiol Regul Intergr 
Comp Physiol 271, R217-R221 
25. Marks-Kaufman, R., Plager, A., and Kanarek, R. B. (1985) Central and peripheral 
contributions of endogenous opioid systems to nutrient selection in rats. Psychopharmacology 
(Berl.) 85, 414-418 
26. Childers, S. R., Creese, I., Snowman, A. M., and Snyder, S. H. (1979) Opiate receptor binding 
affected differentially by opiates and opioid peptides. Eur. J. Pharmacol. 55, 11-18 
27. Bakshi, V. P., and Kelley, A. E. (1993) Feeding induced by opioid stimulation of the ventral 
striatum: role of opiate receptor subtypes. J. Pharmacol. Exp. Ther. 265, 1253-1260 
28. Spanagel, R., Herz, A., and Shippenberg, T. S. (1992) Opposing tonically active endogenous 
opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National 
Academy of Sciences 89, 2046-2050 
29. Naef, L., Moquin, L., Dal Bo, G., Giros, B., Gratton, A., and Walker, C. D. (2011) Maternal 
high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and 
increases motivation for fat rewards in the offspring. Neuroscience 176, 225-236 
30. Chandorkar, G. A., Ampasavate, C., Stobaugh, J. F., and Audus, K. L. (1999) Peptide 
transport and metabolism across the placenta. Adv Drug Delivery Rev 38, 59-67 
31. Lindemalm, S., Nydert, P., Svensson, J.-O., Stahle, L., and Sarman, I. (2009) Transfer of 
Buprenorphine Into Breast Milk and Calculation of Infant Drug Dose. J. Hum. Lact. 25, 199-
205 
32. Robieux, I., Koren, G., Vandenbergh, H., and Schneiderman, J. (1990) Morphine Excretion in 
Breast Milk and Resultant Exposure of a Nursing Infant. Clin. Toxicol. 28, 365-370 
33. Tsang, D., and Ng, S. C. (1980) Effect of antenatal exposure to opiates on the development of 
opiate receptors in rat brain. Brain Res. 188, 199-206 
34. Hammer Jr, R. P., Seatriz, J. V., and Ricalde, A. R. (1991) Regional dependence of morphine-
induced μ-opiate receptor down-regulation in perinatal rat brain. Eur. J. Pharmacol. 209, 253-
256 
35. Burford, N. T., Tolbert, L. M., and Sadee, W. (1998) Specific G protein activation and μ-
opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur. J. 
Pharmacol. 342, 123-126 
36. Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., and 
von Zastrow, M. (1996) Morphine activates opioid receptors without causing their rapid 
internalization. J. Biol. Chem. 271, 19021 
MATERNAL PALATABLE DIET AND OPIOID DESENSITIVITY   27 
 
37. Zadina, J. E., Kastin, A. J., Coy, D. H., and Adinoff, B. A. (1985) Developmental, behavioral, 
and opiate receptor changes after prenatal or postnatal [beta]-endorphin, CRF, or Tyr-MIF-1. 
Psychoneuroendocrinology 10, 367-383 
38. Brands, B., Thornhill, J. A., Hirst, M., and Gowdey, C. W. (1979) Suppression of food intake 
and body weight gain by naloxone in rats. Life Sci. 24, 1773-1778 
39. Cooper, S. J. (1980) Naloxone: Effects on food and water consumption in the non-deprived 
and deprived rat. Psychopharmacology (Berl.) 71, 1-6 
40. Acosta-Martinez, M., and Etgen, A. M. (2002) Estrogen Modulation of Mu-Opioid Receptor-
Stimulated [35S]-GTP-Gamma-S Binding in Female Rat Brain Visualized by in vitro 
Autoradiography. Neuroendocrinology 76, 235-242 
41. Roca, P., Rodriguez, A. M., Oliver, P., Bonet, M. L., Quevedo, S., Picó, C., and Palou, A. 
(1999) Brown adipose tissue response to cafeteria diet-feeding involves induction of the 
UCP2 gene and is impaired in female rats as compared to males. Pflügers Archiv European 
Journal of Physiology 438, 628-634 
 
  
